The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 12, 2014

Filed:

Mar. 29, 2010
Applicants:

Lawrence T. Boni, Monmouth Junction, NJ (US);

Brian S. Miller, Mercerville, NJ (US);

Vladimir Malinin, Plainsboro, NJ (US);

Xingong LI, Robbinsville, NJ (US);

Inventors:

Lawrence T. Boni, Monmouth Junction, NJ (US);

Brian S. Miller, Mercerville, NJ (US);

Vladimir Malinin, Plainsboro, NJ (US);

Xingong Li, Robbinsville, NJ (US);

Assignee:

Insmed Incorporated, Monmouth Junction, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/127 (2006.01); A61K 31/407 (2006.01); A61K 9/00 (2006.01); A61K 31/496 (2006.01); A61K 31/704 (2006.01); A61K 31/545 (2006.01); A61K 31/4709 (2006.01);
U.S. Cl.
CPC ...
A61K 9/127 (2013.01); A61K 9/1277 (2013.01); A61K 31/407 (2013.01); A61K 9/0078 (2013.01); A61K 31/496 (2013.01); A61K 31/704 (2013.01); A61K 31/545 (2013.01); A61K 31/4709 (2013.01);
Abstract

Provided are lipid antiinfective formulations substantially free of anionic lipids with a lipid to antiinfective ratio is about 1:1 to about 4:1, and a mean average diameter of less than about 1 μm. Also provided is a method of preparing a lipid antiinfective formulation comprising an infusion process. Also provided are lipid antiinfective formulations wherein the lipid to drug ratio is about 1:1 or less, about 0.75:1 or less, or about 0.50:1 or less prepared by an in line fusion process. The present invention also relates to a method of treating a patient with a pulmonary infection comprising administering to the patient a therapeutically effective amount of a lipid antiinfective formulation of the present invention. The present invention also relates to a method of treating a patient for cystic fibrosis comprising administering to the patient a therapeutically effective amount of a lipid antiinfective formulation of the present invention.


Find Patent Forward Citations

Loading…